戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 but negative MIBI scans failed to respond to multidrug therapy.
2 In 1985, 5.3 million patients were receiving multidrug therapy; by 1991, this figure had decreased to
3 which owed much to WHO and the donors of the multidrug therapy components, prompted WHO in 1991 to se
4 ibitors (NNRTIs) are important components of multidrug therapy for HIV-1.
5 icipants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the
6               The patient was started on WHO multidrug therapy for paucibacillary leprosy along with
7 e in patients already receiving contemporary multidrug therapy for this disease, the use of digitalis
8     Early diagnostic efforts and advances in multidrug therapy have considerably prolonged the surviv
9               Widespread BCG vaccination and multidrug therapy have dramatically reduced worldwide le
10                                              Multidrug therapy increases the risk for drug-drug inter
11 th substantial morbidity, and standard daily multidrug therapy is difficult to tolerate.
12 ation of bacilli that survive in the face of multidrug therapy or in the generation of multidrug-resi
13         No infected child treated early with multidrug therapy progressed to AIDS or died by 1 year,
14 d control measures for treating leprosy with multidrug therapy should control the spread of drug-resi
15                                              Multidrug therapy suppressed plasma HIV RNA to undetecta
16 , received a mean of 16.1 +/- 10.8 months of multidrug therapy that included EMB.
17 unction and/or proteinuria, lowering BP with multidrug therapy that is inclusive of pharmacologic mod
18                       With the prevalence of multidrug therapy, there is great potential for serious
19 rs focus on the design and implementation of multidrug therapies to target complementary cancer speci
20 ex granulomatous disease, requires long-term multidrug therapy to overcome tolerance, an epigenetic d
21 obal implementation of this highly effective multidrug therapy took about 15 years.
22 uring pregnancy or birth to Zdv if effective multidrug therapy was not initiated.
23 oaches including lifestyle modifications and multidrug therapy will be required in most cases to opti
24 rmat, treatment of TB requires six months of multidrug therapy with a mixture of broad spectrum and m

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。